Unicycive Therapeutics Insider Trades

UNCY

Track insider trading activity from Unicycive Therapeutics executives and directors. See which insiders are buying and selling UNCY stock.

Trades Last 12 Months

UNCY Price

All Insider Trades for Unicycive Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $592k 169,500 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.45M 169,500 shares
$8.56
$3.49
Gupta Pramod Evp, Pharmaceuticals And BD
Holding Value $592k 169,500 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.45M 169,500 shares
$8.56
$3.49
Holding Value $2.66M 762,200 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.52M 762,200 shares
$8.56
$3.49
Jermasek Douglas Evp, Corporate Strategy
Holding Value $592k 169,500 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.45M 169,500 shares
$8.56
$3.49
Holding Value $167k 47,941 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$410k 47,941 shares
$8.56
$3.49
Laumas Sandeep Director
Holding Value $167k 47,941 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$410k 47,941 shares
$8.56
$3.49
Aggarwal Gaurav Director
Holding Value $6.25M 1,789,915 shares
Last Trade
Aug 25, 2025 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$2.8M 652,900 shares
$4.29
$3.49
Ryan John L Director
Holding Value $432k 123,775 shares
Last Trade
Sep 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$852k 112,147 shares
$7.60
$3.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up